Fumitaka Suzuki Hitomi Sezaki Norio Akuta Yoshiyuki Suzuki Yusuke Kawamura Tetsuya Hosaka Masahiro Kobayashi Satoshi Saitoh Yasuji Arase Kenji Ikeda Mariko Kobayashi Sachiyo Watahiki Rie Mineta Yukiko Suzuki Hiromitsu Kumada
10.2147/DDDT.S65349
Drug Des Devel Ther
2014 Jun 30;8:869-73.
hepatitis b virus resistant
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25061278/
Adenine / analogs & derivatives Antiviral Agents / therapeutic use Guanine / analogs & derivatives Hepatitis B, Chronic / drug therapy Organophosphonates / therapeutic use
Adenine / analogs & derivatives Antiviral Agents / therapeutic use Guanine / analogs & derivatives Hepatitis B, Chronic / drug therapy Organophosphonates / therapeutic use Case Reports Research Support, Non-U.S. Gov't Adenine / administration & dosage Adenine / therapeutic use Amino Acid Substitution Antiviral Agents / administration & dosage DNA, Viral / blood Drug Resistance, Viral Drug Therapy, Combination Female Genotype Guanine / administration & dosage Guanine / therapeutic use Hepatitis B e Antigens / blood Hepatitis B virus / genetics Hepatitis B virus / isolation & purification Hepatitis B, Chronic / virology Humans Middle Aged Organophosphonates / administration & dosage Tenofovir Treatment Outcome Antiviral Agents DNA, Viral Hepatitis B e Antigens Organophosphonates entecavir Guanine Tenofovir Adenine
PMC4085295
25061278
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
2014